Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage-secreted brain-derived neurotrophic factor promotes tumor growth in triple-negative breast cancer by inducing axonogenesis.

Cell death and differentiation·2026
Same author

Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.

Journal of neuro-oncology·2026
Same author

Development of PROTACs for targeted degradation of oncogenic TRK fusions.

RSC chemical biology·2026
Same author

Beyond Histology: A Unified Transcriptomic Atlas Defines Lung Cancer Biologic States and Subtypes.

bioRxiv : the preprint server for biology·2026
Same author

A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.

Nature·2026

Related Experiment Video

Updated: Dec 28, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.3K

Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma.

Peter B Dirks1, Mark R Gilbert2, Eric C Holland3

  • 1Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|February 16, 2020
PubMed
Summary

Scientists and clinicians met to address challenges in translating glioblastoma (GBM) basic science discoveries into treatments that improve patient survival. This article summarizes key discussion points from the meeting.

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.5K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Related Experiment Videos

Last Updated: Dec 28, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.3K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.5K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Area of Science:

  • Neuro-oncology
  • Translational Science
  • Glioblastoma Research

Background:

  • Glioblastoma (GBM) remains a challenging brain tumor with limited treatment options.
  • Translating basic science discoveries into effective clinical therapies for GBM is a significant hurdle.

Purpose of the Study:

  • To summarize key challenges and opportunities in glioblastoma translational science.
  • To foster discussion and collaboration within the neuro-oncology community.

Main Methods:

  • Expert meeting and discussion.
  • Synthesis of key points from scientific and clinical neuro-oncology community members.

Main Results:

  • Identified critical barriers in the translation of basic science for glioblastoma.
  • Highlighted potential strategies and opportunities to overcome these barriers.

Conclusions:

  • Accelerating the translation of glioblastoma research is crucial for improving patient outcomes.
  • Collaborative efforts are needed to bridge the gap between basic science and clinical application in neuro-oncology.